Digital Twin Experiment Legality.
1. Introduction
Digital Twin Experiment Legality is an emerging area of technology law concerned with the legal validity, regulatory compliance, ethical boundaries and liability arising from experiments conducted through digital twins.
A digital twin is a virtual representation of a real-world object, person, biological system, industrial facility or infrastructure. It uses real-time data, artificial intelligence (AI), sensors, simulation models and predictive algorithms to reproduce or forecast the behaviour of its physical counterpart.
For example:
A digital twin of a human heart can simulate the effects of different medical treatments.
A digital twin of a patient can predict disease progression.
A digital twin of a pharmaceutical manufacturing plant can test production conditions.
A digital twin of a nuclear power plant can simulate emergency scenarios.
A digital twin of a city can test traffic management and environmental policies.
The legal problem arises when experiments performed on virtual models influence real-world decisions, affect individual rights, create safety risks or substitute for physical testing.
Digital twin experiments are not automatically illegal. Their legality depends on the purpose, data used, reliability of the model, regulatory permissions, informed consent, safety safeguards and consequences of decisions based on their results.
2. Meaning and Scope of Digital Twin Experimentation
Digital twin experimentation involves testing hypothetical conditions or interventions on a computational representation before applying them to the physical counterpart.
Its principal components include:
Physical entity: The actual person, machine, building, organism or infrastructure.
Digital representation: The virtual model representing the physical entity.
Data acquisition: Collection of medical, biometric, environmental, industrial or operational information.
Simulation engine: Software that models possible outcomes.
Experimental intervention: Testing alternative treatments, conditions, designs or operational changes.
Validation: Comparing simulated outcomes with real-world observations.
Implementation: Applying experimental findings to real-world decisions.
The distinction between simulation and experimentation is legally significant. A simulation that merely predicts an outcome may present fewer regulatory concerns than a system that tests interventions and automatically implements decisions affecting people.
3. Legal Framework Governing Digital Twin Experiments in India
India does not yet have a comprehensive, standalone statute specifically governing digital twin experimentation. Instead, legality is determined by applying existing laws on privacy, medical devices, clinical research, intellectual property, cybersecurity, consumer protection and scientific evidence.
A. Constitutional protection of privacy
Article 21 of the Constitution protects life and personal liberty, including the right to privacy.
A digital twin constructed from an individual's:
Medical history;
Genetic information;
Biometric information;
Behavioural patterns;
Physiological measurements; or
Personal health records
may interfere with privacy if information is collected, processed or shared without a lawful basis.
Important case: Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1
The Supreme Court recognised privacy as a fundamental right. Its constitutional reasoning establishes important principles for digital twin experiments:
Processing personal information must have a legal basis.
Restrictions on privacy must satisfy legality, legitimate purpose and proportionality.
Individuals must receive meaningful protection against arbitrary interference.
Sensitive personal information requires appropriate safeguards.
Application: A hospital developing patient-specific digital twins cannot treat access to medical records as unlimited permission to conduct every conceivable experiment.
B. Digital Personal Data Protection Act, 2023
The Digital Personal Data Protection Act, 2023 governs the processing of digital personal data within its territorial scope.
Important compliance issues include:
Lawful processing and consent requirements.
Clear notification of processing purposes.
Appropriate security safeguards.
Restrictions and conditions concerning further processing.
Rights available to data principals.
Obligations of data fiduciaries.
For digital twin experimentation, an important question is whether data collected for treatment can subsequently be used to train a commercial simulation model.
Such secondary processing must be assessed against the applicable statutory requirements; original access to medical data does not automatically authorize unrelated commercial use.
The Act and its 2025 Rules have a phased commencement framework, so the provisions applicable to a particular experiment must be checked against their effective dates.
India Code+1
C. Information Technology Act, 2000
The Information Technology Act, 2000 and applicable rules provide an additional framework for digital information and cybersecurity.
Relevant issues include:
Unauthorized access to digital twin databases.
Unauthorized extraction of patient information.
Data manipulation.
Cyberattacks against simulation infrastructure.
Negligent protection of sensitive information.
Where a digital twin experiment involves unauthorized access or manipulation of computer resources, applicable provisions of the IT Act may become relevant.
D. Medical Devices Rules, 2017
The Medical Devices Rules, 2017 are particularly important when digital twin software is designed for medical purposes.
For example, software that simulates an individual patient's heart to recommend treatment or predict the effects of a drug may fall within medical-device regulation depending on its intended purpose and functionality.
Important compliance considerations include:
Classification of the software or device.
Safety and performance requirements.
Software verification and validation.
Technical documentation.
Clinical investigation requirements, where applicable.
Regulatory permission before conducting regulated clinical investigations.
Rules 43–45 address clinical investigations of investigational medical devices. Rule 43 requires compliance with the applicable rules and permission from the Central Licensing Authority for relevant human-participant investigations.
IndiaCode+1
Legal distinction: An experiment conducted entirely on a computational model is not automatically a clinical investigation involving human participants. However, this does not exempt the resulting software from medical-device requirements or remove obligations applicable to research using human-derived data.
E. Clinical research and informed consent
Digital twin experiments in medicine may involve clinical research regulations, ethics committee oversight and informed consent.
The legal distinction is between:
Testing a model using previously collected data;
Simulating a proposed treatment;
Using the simulation to guide patient treatment; and
Testing the recommended intervention on an actual patient.
Each activity can trigger different legal obligations.
Where actual human participants are involved, the applicable clinical research requirements cannot be avoided simply by describing the experiment as a digital twin project.
4. Major Legal Issues in Digital Twin Experimentation
4.1 Informed consent and experimental autonomy
A central legal issue is whether individuals have adequately consented to the creation and experimental use of their digital representations.
For example, a patient may consent to the use of medical records for diagnosis but may not have consented to:
Commercial development of digital twins;
Testing experimental drugs on their virtual representation;
Sharing genetic information with technology companies;
Predicting future health risks;
Training unrelated AI systems.
Consent should explain the nature and purpose of the experiment, the relevant data, foreseeable risks and the intended use of results.
Case law: Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1
The Supreme Court of India examined informed consent in medical treatment.
The judgment establishes that consent must relate to the particular treatment or procedure proposed. Consent to one medical intervention cannot automatically be treated as consent to a substantially different intervention.
Application: Consent to medical treatment or data collection should not automatically be interpreted as unrestricted consent to experimental interventions or unrelated digital twin research.
4.2 Medical negligence and simulation errors
Digital twins may produce inaccurate predictions because of:
Incomplete datasets;
Incorrect assumptions;
Biased training information;
Faulty algorithms;
Outdated patient information;
Poor validation;
Unexpected interactions between variables.
Suppose a digital twin predicts that a patient can safely receive a particular drug dosage. A doctor relies on that prediction, but the patient suffers serious injury.
Potentially liable parties may include:
The treating medical professional.
The hospital or healthcare institution.
The digital twin software developer.
The medical-device manufacturer.
The research sponsor.
The data provider, where its conduct independently creates liability.
Liability depends on the applicable duty of care, causation, contractual arrangements, regulatory compliance and the conduct of each party.
Case law: Indian Medical Association v. V.P. Shantha (1995) 6 SCC 651
The Supreme Court considered the applicability of consumer protection law to medical services.
Application: Where defective digital twin technology forms part of paid healthcare services, consumer protection principles may become relevant. A patient may potentially pursue a claim where deficient services cause legally recognised harm.
Case law: Jacob Mathew v. State of Punjab (2005) 6 SCC 1
The Supreme Court explained principles governing medical negligence, including the standard of professional care.
Application: A medical professional should not rely blindly on a digital twin's prediction. The clinician's independent professional judgment and the reliability of the supporting technology remain important.
4.3 Scientific reliability and experimental validity
A digital twin experiment must have a scientifically defensible methodology.
Questions include:
Is the underlying model scientifically valid?
Has the simulation been independently tested?
Are the assumptions documented?
Can another researcher reproduce the results?
Are limitations and error rates disclosed?
Does the model accurately represent the relevant physical system?
A simulation should not be treated as scientifically conclusive merely because it produces sophisticated graphs or numerical predictions.
4.4 Discrimination and algorithmic bias
Digital twins based on population datasets may reproduce historical discrimination.
For example, a healthcare digital twin may produce inaccurate risk assessments for certain demographic groups because its training data disproportionately represents another population.
This can lead to:
Unfair insurance decisions;
Discriminatory medical recommendations;
Employment-related discrimination;
Unequal access to treatment;
Inaccurate public health predictions.
The legality of such decisions depends on applicable constitutional, statutory and sector-specific protections.
4.5 Intellectual property ownership
Digital twin experiments create complicated intellectual property questions.
A single digital twin may incorporate:
Patient-generated information;
Hospital databases;
Proprietary algorithms;
Software code;
Research datasets;
Simulation outputs;
AI-generated predictions.
The legal ownership of the software and the rights concerning personal information are separate questions.
A developer may own copyright in original software without thereby acquiring unrestricted ownership or use rights over the personal data used to construct the twin.
Contractual agreements should clarify ownership, licensing, confidentiality, commercial exploitation and research publication rights.
4.6 Cybersecurity and unauthorized experimentation
A malicious person could manipulate a digital twin to generate false results.
For example, manipulating a digital twin of an aircraft engine could cause engineers to underestimate mechanical failure risks.
Such conduct may give rise to:
Cybercrime liability;
Contractual liability;
Regulatory penalties;
Product liability;
Professional negligence;
Criminal liability where applicable.
Security testing must itself be authorized and appropriately controlled.
5. Important Case Laws Relevant to Digital Twin Experiment Legality
There is currently no established body of reported Indian judgments specifically deciding the legality of digital twin experiments. The following judgments provide important legal principles by analogy.
A. Indian case laws
| Case | Legal principle | Relevance to digital twins |
|---|---|---|
| Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1 | Fundamental right to privacy | Protection of patient data and digital identity |
| Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1 | Informed medical consent | Consent for experimental medical applications |
| Jacob Mathew v. State of Punjab (2005) 6 SCC 1 | Standard of medical negligence | Negligent reliance on inaccurate simulations |
| Indian Medical Association v. V.P. Shantha (1995) 6 SCC 651 | Consumer protection in medical services | Claims involving defective digital healthcare |
| Arjun Panditrao Khotkar v. Kailash Kushanrao Gorantyal (2020) 7 SCC 1 | Authentication of electronic records | Reliability and admissibility of digital experiment records |
| Anvar P.V. v. P.K. Basheer (2014) 10 SCC 473 | Electronic evidence requirements | Authentication of simulation records and electronic outputs |
B. Detailed judicial analysis
1. Justice K.S. Puttaswamy v. Union of India (2017)
The Supreme Court recognised privacy as a constitutionally protected fundamental right under Article 21.
Its importance for digital twin experiments is substantial because digital representations can combine several categories of personal information into a detailed predictive profile.
A digital twin may reveal information that an individual has never expressly disclosed, including predicted health conditions and behavioural characteristics.
The judgment provides constitutional principles for evaluating whether such processing is lawful, necessary and proportionate.
2. Samira Kohli v. Dr. Prabha Manchanda (2008)
This case concerned the requirement of informed consent before medical treatment.
The Supreme Court distinguished consent for a particular procedure from consent for a different or additional procedure.
Its relevance is that researchers and healthcare institutions should not assume that permission to collect patient information authorises every future experiment using that information.
For example, permission to create a digital twin for treatment should not automatically be treated as permission to use it for commercial pharmaceutical experimentation.
3. Jacob Mathew v. State of Punjab (2005)
The Supreme Court discussed the professional standard required to establish medical negligence.
The judgment is relevant where a doctor relies on a digital twin to make a clinical decision.
A software recommendation cannot automatically eliminate the professional responsibility of a treating doctor. The relevant question is whether the doctor acted with the degree of reasonable skill and care expected in the circumstances.
4. Arjun Panditrao Khotkar v. Kailash Kushanrao Gorantyal (2020)
This judgment considered the admissibility and certification of electronic records under the former Indian Evidence Act.
Its significance is that digital twin experiment logs, simulation outputs, electronic communications and system-generated records may need appropriate authentication when relied upon in litigation.
The current evidentiary framework is the Bharatiya Sakshya Adhiniyam, 2023, including Section 63 concerning admissibility of electronic records.
A party relying on simulation evidence must establish the applicable evidentiary requirements rather than merely presenting a computer-generated prediction.
C. International case laws
5. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)
The United States Supreme Court established an important framework for assessing the reliability and relevance of scientific expert evidence.
Relevant considerations include:
Whether the methodology can be tested;
Whether it has been subjected to peer review;
Its known or potential error rate;
The existence of relevant standards;
Its acceptance within the relevant scientific community.
Application: A digital twin experiment offered as scientific evidence should be supported by a reliable methodology rather than technological sophistication alone.
6. General Electric Co. v. Joiner, 522 U.S. 136 (1997)
The US Supreme Court examined the connection between the scientific data and the expert's conclusions.
The decision is important because a conclusion may be excluded when there is an excessive analytical gap between the underlying evidence and the opinion derived from it.
Application: If a digital twin predicts that an industrial component will fail, the expert must demonstrate how the available data and simulation methodology support that prediction.
7. Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999)
The US Supreme Court extended the reliability assessment to technical and specialised expert testimony.
Application: Digital twin evidence concerning engineering, biotechnology, healthcare and industrial systems should be assessed according to the reliability of the particular technical methodology.
Important qualification: These three US decisions concern scientific and expert evidence, not the direct authorization of digital twin experiments. They are comparative authorities rather than binding Indian precedents.
6. Digital Twin Experimentation in Different Sectors
A. Healthcare and biotechnology
Simulating organs, disease progression, drug responses and surgical interventions.
Legal concerns: informed consent, medical-device regulation, research ethics, patient safety and data protection.
B. Pharmaceutical experimentation
Testing manufacturing conditions and predicting drug performance.
Legal concerns: Good Manufacturing Practices, clinical evidence, product safety and regulatory approval.
Digital Twin in Indian Manufacturing: Use Cases, Benefits & ROI Guide (2026) | EMERSIT
C. Industrial engineering
Simulating machinery failure, production processes and equipment safety.
Legal concerns: occupational safety, product liability, negligence and technical standards.
RACLAB — Robotics, Automation & Control Laboratory | Konya Technical University
D. Smart cities and public infrastructure
Testing traffic, environmental conditions, water systems and emergency responses.
Legal concerns: surveillance, public accountability, privacy, procurement and infrastructure safety.
E. Aerospace and transportation
Testing aircraft, vehicle and engine performance under simulated conditions.
Legal concerns: aviation safety, certification, product liability and negligent risk assessment.
7. Comparative International Regulatory Framework
European Union
The EU framework is particularly relevant to patient-specific digital twins.
Important instruments include:
General Data Protection Regulation (GDPR), particularly Articles 5, 6, 9 and 22.
Medical Device Regulation (EU) 2017/745.
Artificial Intelligence Act (EU) 2024/1689.
European Health Data Space Regulation (EU) 2025/327.
A healthcare digital twin may involve sensitive health-data processing under GDPR. If its intended purpose falls within medical-device software regulation, the MDR may also apply.
AI-enabled digital twins may additionally fall within the AI Act, depending on their purpose, classification and deployment.
The European Health Data Space also creates a framework for health-data access and secondary use, subject to applicable safeguards.
International Bar Association+1
United States
The principal regulatory framework includes:
Federal Food, Drug, and Cosmetic Act.
FDA medical-device regulations.
HIPAA, where applicable.
Common Rule requirements for covered human-subject research.
State privacy and consumer protection laws.
The FDA's approach to computational modelling and simulation recognises the potential value of computer-generated evidence in medical-device development. However, a simulation is not automatically accepted as sufficient evidence for regulatory approval.
Australia
Relevant Australian frameworks include:
Therapeutic Goods Act 1989.
Therapeutic Goods (Medical Devices) Regulations 2002.
Privacy Act 1988.
National Statement on Ethical Conduct in Human Research.
Australian clinical trial governance and ethics requirements.
Where a digital twin qualifies as a medical device, applicable TGA requirements must be considered. Research involving human participants may also require appropriate ethics review and consent.
8. When Does a Digital Twin Experiment Become Illegal?
A digital twin experiment may become legally problematic in the following circumstances:
| Conduct | Potential legal consequence |
|---|---|
| Using personal data without a lawful basis | Data protection liability |
| Conducting regulated human-participant research without required permission | Regulatory and potentially criminal consequences |
| Deploying unapproved regulated medical-device software | Medical-device regulatory action |
| Manipulating simulation results | Fraud, research misconduct or civil liability |
| Using inaccurate predictions negligently | Professional or product liability |
| Sharing confidential patient information unlawfully | Privacy and confidentiality liability |
| Conducting unauthorized cybersecurity experiments | Cybercrime liability |
| Misappropriating proprietary simulation software | Intellectual property infringement |
The precise consequence depends on the applicable legislation and facts.
9. Legal Responsibilities of Stakeholders
Digital twin experimentation involves several potentially responsible parties.
Researchers
Maintain scientific integrity.
Document experimental methodology.
Disclose model limitations.
Obtain appropriate ethical approvals.
Technology developers
Validate software performance.
Protect data against unauthorized access.
Maintain technical documentation.
Disclose known defects and limitations.
Hospitals and research institutions
Obtain appropriate consent.
Maintain confidentiality.
Ensure regulatory and ethics compliance.
Monitor clinical applications.
Regulators
Establish appropriate safety standards.
Assess the reliability of relevant technologies.
Investigate non-compliance.
Protect public and individual interests.
Manufacturers and commercial operators
Maintain product safety.
Provide accurate technical information.
Monitor post-deployment performance.
Address defects and foreseeable risks.
10. Proposed Legal Principles for Digital Twin Experiment Governance
A comprehensive legal framework should recognise the following principles:
1. Principle of experimental authorization: Experiments involving regulated physical interventions must obtain the permissions required by applicable law.
2. Principle of informed digital consent: Individuals should understand how their information and digital representations will be used.
3. Principle of scientific validation: Digital twin results must undergo appropriate verification and validation.
4. Principle of model transparency: Relevant assumptions, limitations and error rates should be documented.
5. Principle of human oversight: High-impact decisions should have appropriate human review.
6. Principle of data minimisation: Only information necessary for the experiment should be processed.
7. Principle of algorithmic accountability: Developers and operators should be accountable for their respective decisions and conduct.
8. Principle of experimental traceability: Experiment versions, datasets, model changes and results should be documented.
9. Principle of proportionality: The risks of experimentation should be proportionate to its legitimate scientific or commercial purpose.
10. Principle of post-experiment responsibility: Legal responsibility should continue where experimental results are deployed in real-world systems.
11. Important Emerging Legal Challenges
Several unresolved questions may shape the future of digital twin law.
A. Can a digital human twin have independent legal rights?
Current legal systems generally do not recognise a computational representation of a person as a separate legal person merely because it reproduces human characteristics.
B. Can virtual experimentation replace physical clinical trials?
Simulation may reduce the need for some physical testing, but whether it can replace particular clinical investigations depends on scientific validation and regulatory acceptance.
C. Who owns an experimental digital twin?
Ownership of software, copyright, databases and contractual rights must be distinguished from an individual's rights concerning personal information.
D. Who is responsible when a digital twin produces a false prediction?
Responsibility may be distributed between developers, manufacturers, research institutions and professionals. The applicable duty, breach, causation and damage must be established.
E. Can a digital twin be used for experiments without the individual's knowledge?
This raises serious consent, privacy, confidentiality and data-protection issues, particularly when identifiable health or biometric information is involved.
12. Conclusion
Digital Twin Experiment Legality represents an emerging intersection of artificial intelligence law, biotechnology law, medical-device regulation, constitutional privacy, scientific evidence and product liability.
The central legal question is not simply whether an experiment takes place in a virtual environment. It is whether the experiment uses information lawfully, follows applicable research and regulatory requirements, produces scientifically reliable results and protects individuals from foreseeable harm.
In India, constitutional privacy principles, the Digital Personal Data Protection Act, 2023, the Medical Devices Rules, 2017, the IT Act, 2000 and the Bharatiya Sakshya Adhiniyam, 2023 provide important elements of the applicable legal framework.
The decisions in Puttaswamy, Samira Kohli and Jacob Mathew offer particularly important judicial principles for privacy, informed consent and professional responsibility.
Ultimately, digital twin experimentation should be governed by a principle of virtual innovation with real-world accountability.
13. Important Legal References and Research Sources
For further academic research:
Digital Personal Data Protection Act, 2023 – India Code.
Medical Devices Rules – India.
The Rise of Digital Twins in Healthcare: Some Legal Insights – International Bar Association.
Realising the Digital Twin: Ethical, Legal and Social Issues – AI & Society.
UK Guide to Good Practice for Digital Health Technologies.
Digital Twin Technology: Public Health and Legal Challenges.
Academic qualification: The case laws discussed above are relevant judicial precedents applied by analogy. They should not be cited as judgments directly deciding digital twin experimentation.
I can also develop this subject into a research-paper chapter covering Digital Twin Experiment Legality in India, Australia, the EU and the United States, with additional case-law analysis and regulatory comparisons.
RELATED Blog
comments